CN1146772A - 用于治疗过敏反应的合成肽免疫原 - Google Patents

用于治疗过敏反应的合成肽免疫原 Download PDF

Info

Publication number
CN1146772A
CN1146772A CN95192778A CN95192778A CN1146772A CN 1146772 A CN1146772 A CN 1146772A CN 95192778 A CN95192778 A CN 95192778A CN 95192778 A CN95192778 A CN 95192778A CN 1146772 A CN1146772 A CN 1146772A
Authority
CN
China
Prior art keywords
gly
lys
peptide
phe
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95192778A
Other languages
English (en)
Chinese (zh)
Inventor
C·Y·王
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Biomedical Inc
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of CN1146772A publication Critical patent/CN1146772A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN95192778A 1994-03-28 1995-03-24 用于治疗过敏反应的合成肽免疫原 Pending CN1146772A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21846194A 1994-03-28 1994-03-28
US08/218,461 1994-03-28
US32891294A 1994-10-25 1994-10-25
US08/328,912 1994-10-25

Publications (1)

Publication Number Publication Date
CN1146772A true CN1146772A (zh) 1997-04-02

Family

ID=26912926

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95192778A Pending CN1146772A (zh) 1994-03-28 1995-03-24 用于治疗过敏反应的合成肽免疫原

Country Status (6)

Country Link
EP (1) EP0811016A1 (enrdf_load_stackoverflow)
JP (1) JPH09510975A (enrdf_load_stackoverflow)
CN (1) CN1146772A (enrdf_load_stackoverflow)
AU (1) AU2195395A (enrdf_load_stackoverflow)
CA (1) CA2186595A1 (enrdf_load_stackoverflow)
WO (1) WO1995026365A1 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112237638A (zh) * 2020-10-28 2021-01-19 西安华牧生物科技有限责任公司 降低放射性核素肾浓聚的组合探针及其制备方法

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843462A (en) 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
NZ331651A (en) 1996-03-01 2000-01-28 Novartis Ag BSW17 peptide immunogens for vaccination against and treatment of allergy
GB9611673D0 (en) * 1996-06-05 1996-08-07 Peptide Therapeutics Ltd Meningococcal vaccine
CA2315537A1 (en) 1997-12-16 1999-06-24 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
TWI227241B (en) * 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
US6090388A (en) * 1998-06-20 2000-07-18 United Biomedical Inc. Peptide composition for prevention and treatment of HIV infection and immune disorders
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
MXPA01010625A (es) 1999-04-23 2003-09-04 Pharmexa As Metodo para regulacion por disminucion de la actividad de interleucina 5.
GB9913327D0 (en) * 1999-06-08 1999-08-11 Smithkline Beecham Biolog Vaccine
US6846486B1 (en) 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
WO2001069253A2 (en) * 2000-03-15 2001-09-20 Heska Corporation 3d model of an fc epsilon receptor alpha chain-ige fc region complex
AU7658101A (en) * 2000-07-28 2002-02-13 Cytos Biotechnology Ag Compositions for inducing self-specific anti-ige antibodies and uses thereof
AU2001285721A1 (en) * 2000-09-06 2002-03-22 Pharmexa A/S Method for down-regulating IgE
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
JP2003047482A (ja) 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
US7604955B2 (en) 2001-08-13 2009-10-20 Swey-Shen Alex Chen Immunoglobulin E vaccines and methods of use thereof
IL158287A0 (en) * 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
WO2009023816A1 (en) * 2007-08-15 2009-02-19 Emory University Methods of making monoclonal antibodies using fusion- peptide epitope adoptive transfer (f-peat) technology
AU2009222974A1 (en) * 2008-03-13 2009-09-17 Compugen Ltd. Novel gp96 derived peptides
DK2788021T3 (en) 2011-12-09 2017-04-10 Bavarian Nordic As POXVIRUS VECTOR FOR EXPRESSION OF BACTERIAL ANTIGENES CONNECTED TO TETANANOX INFRAGMENT C
US9187553B2 (en) * 2012-01-25 2015-11-17 Swey-Shen Chen Displaying native human IgE neutralizing FcepsilonRIa-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold
US9657071B2 (en) * 2012-06-18 2017-05-23 Nippon Zenyaku Kogyo Co., Ltd. IgE peptide vaccine
EP2790442A1 (en) 2013-04-09 2014-10-15 Alcatel Lucent Control system, apparatus, methods, and computer readable storage medium storing instructions for a network node and/or a network controller

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5552537A (en) * 1993-03-24 1996-09-03 The Regents Of The University Of California IgE isoforms and methods of use
ES2180576T3 (es) * 1993-04-27 2003-02-16 United Biomedical Inc Construcciones peptidicas de lhrh inmunogenicas y estimuladores de inmunidad universales sinteticos para vacunas.
GB9320897D0 (en) * 1993-10-11 1993-12-01 Peptide Therapeutics Ltd Compounds useful in anti-allergy treatment
GB9417086D0 (en) * 1994-08-24 1994-10-12 Peptide Therapeutrics Limited Screen for potential therapeutic compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112237638A (zh) * 2020-10-28 2021-01-19 西安华牧生物科技有限责任公司 降低放射性核素肾浓聚的组合探针及其制备方法

Also Published As

Publication number Publication date
JPH09510975A (ja) 1997-11-04
EP0811016A4 (enrdf_load_stackoverflow) 1997-12-10
AU2195395A (en) 1995-10-17
WO1995026365A1 (en) 1995-10-05
EP0811016A1 (en) 1997-12-10
CA2186595A1 (en) 1995-10-05

Similar Documents

Publication Publication Date Title
CN1146772A (zh) 用于治疗过敏反应的合成肽免疫原
CN1259340C (zh) 作为免疫原治疗过敏症的肽组合物
CN1201819C (zh) 人工t辅助细胞表位作为合成肽免疫原的免疫刺激物
CN1174998C (zh) 用于预防和治疗过敏的肽免疫原
CN1093881C (zh) 免疫原或诊断剂的制备及其获得免疫原或诊断试剂的方法
CN1354674A (zh) 用于口蹄疫的合成肽疫苗
CN1214114C (zh) 可活化的重组神经毒素
CN1282656C (zh) 来自gagp17和p24保守区域的HIV肽以及它们在例如疫苗中的应用
CN1315869A (zh) 人工t辅助细胞表位作为包括免疫原性lhrh肽的合成肽免疫原的免疫刺激物
CN1118474C (zh) 合成肽及包含其的疫苗
CN1622958A (zh) 促甲状腺素(tsh)受体的表位区域、其用途和针对该区域的抗体
CN1167491A (zh) 用于治疗变态反应的合成IgE膜锚肽免疫原
CN1197968C (zh) 二硫键交联的糖蛋白激素类似物及其制备和应用
CN1668737A (zh) 重组Bet.V.1过敏原突变体及其方法和制备
CN1483736A (zh) 用于生产治疗用乙型肝炎疫苗或药物的免疫原及其制备方法和用途
CN1452634A (zh) Hla结合肽及其用途
CN1116305C (zh) 肽衍生物
CN87105411A (zh) B型肝炎病毒表面抗原前s区的t细胞和b细胞抗原决定基
CN1741818A (zh) 线虫多肽佐剂
CN1718243A (zh) 一类免疫佐剂及其在抗病毒疫苗或药物制备中的应用
CN1653337A (zh) A2超基序亚单位疫苗
CN1311688A (zh) 用于促进畜牧场动物生长的合成的促生长素抑制素免疫原
CN1861194A (zh) 抗胃泌素释放肽核酸疫苗及制备方法
CN1566143A (zh) Sars冠状病毒核衣壳蛋白的抗原决定簇及其应用
CN1290579C (zh) 重组口蹄疫病毒vp1融合蛋白疫苗

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication